Marnitz, Simone and Schoemig-Markiefka, Birgid (2021). The PORTEC-3 trial for high-risk endometrial cancer: impact of molecular classification on prognosis and benefit from adjuvant therapy. Strahlenther. Onkol., 197 (3). S. 266 - 269. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Marnitz, SimoneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schoemig-Markiefka, BirgidUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-568609
DOI: 10.1007/s00066-020-01735-4
Journal or Publication Title: Strahlenther. Onkol.
Volume: 197
Number: 3
Page Range: S. 266 - 269
Date: 2021
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1439-099X
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
RADIOTHERAPY; RADIATIONMultiple languages
Oncology; Radiology, Nuclear Medicine & Medical ImagingMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/56860

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item